Literature DB >> 20801518

Slow enlargement of choroidal nevi: a long-term follow-up study.

Arman Mashayekhi1, Sophia Siu, Carol L Shields, Jerry A Shields.   

Abstract

PURPOSE: Choroidal nevi are generally considered to be stable lesions, and growth of a choroidal nevus is usually believed to be a sign of malignant transformation. We performed this study to determine whether choroidal nevi enlarge over a long period of follow-up without undergoing malignant transformation.
DESIGN: Retrospective observational case series. PARTICIPANTS: A total of 278 patients with 284 nevi who had at least 7 years of photographic follow-up without clinical signs of transformation into melanoma were included in the study.
METHODS: Data on demographic and clinical information were extracted from patients' charts. Detailed fundus drawings and color fundus photographs were reviewed and compared for evidence of enlargement. MAIN OUTCOME MEASURES: Nevus enlargement without clinical evidence of transformation into melanoma.
RESULTS: Of the 278 patients, 69% were female and more than 99% were White with a median age at presentation of 57 years (range, 4-87 years). The largest nevus basal diameter was a median of 5 mm (range, 0.5-14 mm), and the median thickness was 1.5 mm (range, 0.1-3.6 mm). Only 14 nevi (5%) had subretinal fluid outside the nevus, and 6% showed overlying orange pigment. Overlying retinal pigment epithelial alterations included drusen (61%), atrophy (6%), hyperplasia (10%), and fibrous metaplasia (6%). Of 284 nevi, 31% showed slight enlargement over a mean follow-up of 15 years. The median increase in diameter was 1 mm (mean, 0.9 mm; range, 0.2-3.0 mm), and the median rate of enlargement was 0.06 mm/yr (mean, 0.06 mm/yr; range, 0.01-0.36 mm/yr). None of the lesions that enlarged developed new risk factors that are generally associated with malignant transformation. Frequency of enlargement was 54% in patients aged less than 40 years and 19% in patients aged more than 60 years. On multivariate analysis, younger patient age was the only factor predictive of nevus enlargement (P<0.001).
CONCLUSIONS: With long-term follow up, 31% of choroidal nevi showed slight enlargement without clinical evidence of transformation into melanoma. The frequency of enlargement was inversely related to patient age.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 20801518     DOI: 10.1016/j.ophtha.2010.06.006

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Small Choroidal Melanoma: Correlation of Growth Rate with Pathology.

Authors:  Vishal Raval; Shiming Luo; Emily C Zabor; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2021-07-30

2.  Gene Expression Profiling as an Adjunctive Measure to Guide the Management of Indeterminate, High-Risk Choroidal Melanocytic Lesions: A Pilot Study.

Authors:  Ezekiel Weis; Kelsey Roelofs; Matthew Larocque; Albert Murtha
Journal:  Ocul Oncol Pathol       Date:  2018-07-12

3.  Tele-Oncology: A Validation Study of Choroidal and Iris Nevi.

Authors:  Kelsey Roelofs; Ezekiel Weis
Journal:  Ocul Oncol Pathol       Date:  2018-12-13

4.  Fundus Autofluorescence Change as an Early Indicator of Treatment Effect of Brachytherapy for Choroidal Melanomas.

Authors:  Jesintha Navaratnam; Thomas P Bærland; Nils A Eide; Rowan T Faber; Bernt L Rekstad; Demetrios G Vavvas; Ragnheiður Bragadóttir
Journal:  Ocul Oncol Pathol       Date:  2019-05-16

5.  Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.

Authors:  Lamis Al Harby; Mandeep S Sagoo; Roderick O'Day; Gordon Hay; Amit K Arora; Pearse A Keane; Victoria M-L Cohen; Bertil Damato
Journal:  Ocul Oncol Pathol       Date:  2021-03-15

6.  The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?

Authors:  Kelsey A Roelofs; Roderick O'Day; Lamis Al Harby; Amit K Arora; Victoria M L Cohen; Mandeep S Sagoo; Bertil Damato
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

7.  White Paper on Ophthalmic Imaging for Choroidal Nevus Identification and Transformation into Melanoma.

Authors:  Carol L Shields; Sara E Lally; Lauren A Dalvin; Mandeep S Sagoo; Marco Pellegrini; Swathi Kaliki; Ahmet Kaan Gündüz; Minoru Furuta; Prithvi Mruthyunjaya; Adrian T Fung; Jay S Duker; Sara M Selig; Antonio Yaghy; Sandor R Ferenczy; Malvina B Eydelman; Mark S Blumenkranz
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

Review 8.  Can the MOLES acronym and scoring system improve the management of patients with melanocytic choroidal tumours?

Authors:  Bertil E Damato
Journal:  Eye (Lond)       Date:  2022-06-28       Impact factor: 4.456

9.  Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab.

Authors:  Milena L Cavalcante; Victor M Villegas; Aaron S Gold; Ludimila L Cavalcante; Marcela Lonngi; Nisha V Shah; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2014-07-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.